Innovative Safe Sunscreens Technology: Evaluation of Skin Penetration Through In Vitro/In Vivo Assays and Environmental Friendliness
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70538 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Weixiong Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ausmetics Daily Chemicals (Guangzhou) Co., Ltd., Guangzhou, China. Hauptthemen laut MEDLINE: Sunscreening Agents, Skin Absorption. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Conventional sunscreens can penetrate the skin, potentially causing irritation and raising safety concerns. This study introduces a novel sunscreen technology designed to prevent skin penetration while maintaining high efficacy.
Aims
To evaluate the safety, efficacy, and skin penetration profile of an innovative sunscreen that microencapsulated UV filters (octocrylene and avobenzone) within a silk peptide modified polysilicone‐14, and to compare it to a conventional, nonencapsulated formulation.
Methods
The innovative formulation was assessed using a Human Repeated Insult Patch Test (HRIPT) to determine irritation and allergenic potential. Sun protection efficacy was measured in vivo (SPF, PFA). Skin penetration was evaluated using in vitro Franz cell assays with a Strat‐M membrane and in vivo via Raman spectroscopy, which measured penetration into the stratum corneum and epidermis over time. Sensory assessment and tolerability were also conducted on volunteers with sensitive skin.
Results
The HRIPT confirmed the innovative sunscreen was nonirritating and nonallergenic. It demonstrated equivalent sun protection efficacy to the conventional sunscreen, with an SPF of ~30 and PFA of ~10. Crucially, the Franz cell assay showed zero (0.00%) penetration of UV filters for 6 h. Raman spectroscopy confirmed no penetration into the stratum corneum for 4 h and no penetration into the epidermis for 8 h. The formulation was well‐tolerated by sensitive skin volunteers. In contrast, the conventional sunscreen showed significant skin penetration and caused irritation.
Conclusions
The innovative microencapsulation technology successfully creates a safe, non‐skin‐penetrating sunscreen with high UVA/UVB protection. This technology offers a superior safety profile, making it particularly suitable for populations with sensitive skin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ausmetics Daily Chemicals (Guangzhou) Co., Ltd., Guangzhou, China.
- Glowgenix BioTech Ltd., Hong Kong SAR, China.
- Seiwa Kasei Co., Ltd., Higashiosaka, Osaka, Japan.
ORCID-Profile: Xueping Chen
Zitieren
APA
Huang, W., Zhang, W., Tomihisa, S., Kuang, H., Li, R., & Chen, X. (2025). Innovative Safe Sunscreens Technology: Evaluation of Skin Penetration Through In Vitro/In Vivo Assays and Environmental Friendliness. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70538
Vancouver
Huang W, Zhang W, Tomihisa S, Kuang H, Li R, Chen X. Innovative Safe Sunscreens Technology: Evaluation of Skin Penetration Through In Vitro/In Vivo Assays and Environmental Friendliness. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70538
BibTeX
@article{Huang2025,
author = {Huang, Weixiong and Zhang, Wenwen and Tomihisa, Shota and Kuang, Hongjuan and Li, Ru and Chen, Xueping},
title = {Innovative Safe Sunscreens Technology: Evaluation of Skin Penetration Through In Vitro/In Vivo Assays and Environmental Friendliness},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70538}
}
EUVIMED